<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04073992</url>
  </required_header>
  <id_info>
    <org_study_id>833798</org_study_id>
    <nct_id>NCT04073992</nct_id>
  </id_info>
  <brief_title>Chronic Insomnia and CSF Markers of Dementia - Effects of Treatment</brief_title>
  <official_title>Chronic Insomnia and CSF Markers of Dementia - Effects of Treatment</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Pennsylvania</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Pennsylvania</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The longstanding view has been that insomnia, and other forms of sleep disturbance, emerge as&#xD;
      a consequence of dementia and are the result of progressive neuronal damage. However, there&#xD;
      is growing evidence that the direction of causation may go both ways, with sleep disturbance&#xD;
      potentially increasing vulnerability to dementia. Longitudinal studies have found that sleep&#xD;
      disturbance often precedes and increases risk for dementia by several years. The purpose of&#xD;
      this study is to examine whether treatment of insomnia with cognitive behavioral therapy&#xD;
      (CBT-I) is associated with a decrease in dementia biomarkers found in cerebrospinal fluid&#xD;
      (CSF). Fifteen adults age 30-50 with chronic insomnia will undergo overnight polysomnography&#xD;
      and CSF sampling in the morning. This will be followed by 8 weeks of treatment with CBT-I and&#xD;
      then repeat CSF sampling.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 1, 2019</start_date>
  <completion_date type="Anticipated">December 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">November 30, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>CSF markers related to dementia</measure>
    <time_frame>8 weeks</time_frame>
    <description>CSF levels of the proteins tau and beta amyloid</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">15</enrollment>
  <condition>Insomnia Chronic</condition>
  <arm_group>
    <arm_group_label>Cognitive behavioral treatment of insomnia (CBT-I)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Eight weeks of cognitive behavioral treatment of insomnia.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>cognitive behavioral treatment of insomnia</intervention_name>
    <description>A behavioral modification program consisting of 8 clinic sessions focused on sleep hygiene, stimulus control, sleep restriction, and cognitive restructuring.</description>
    <arm_group_label>Cognitive behavioral treatment of insomnia (CBT-I)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age 30-50&#xD;
&#xD;
          -  Men and women&#xD;
&#xD;
          -  Meet DSM5 Diagnostic Criteria for insomnia disorder&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Diagnosis or evidence of sleep disorders other than insomnia as determined by the&#xD;
             screening questionnaires and clinical history&#xD;
&#xD;
          -  Women who have been pregnant or lactating within the past six months&#xD;
&#xD;
          -  Non-fluency in spoken or written English&#xD;
&#xD;
          -  Current or past month shiftwork defined as working during the evening or night shift&#xD;
&#xD;
          -  Current use of medications or OTC products that impact sleep&#xD;
&#xD;
          -  Evidence of neurological abnormalities that could include the risks associated with&#xD;
             lumbar puncture (e.g.papilledema, mass lesion, Chiari malformation).&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Philip Gehrman, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Pennsylvania</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Paul Gunter, MA</last_name>
    <phone>215-746-1258</phone>
    <email>Paul.Gunter@pennmedicine.upenn.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of Pennsylvania</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Paul Gunter, M.S.</last_name>
      <phone>215-746-1258</phone>
      <email>paul.gunter@pennmedicine.upenn.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>August 27, 2019</study_first_submitted>
  <study_first_submitted_qc>August 27, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">August 29, 2019</study_first_posted>
  <last_update_submitted>January 12, 2021</last_update_submitted>
  <last_update_submitted_qc>January 12, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 13, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dementia</mesh_term>
    <mesh_term>Sleep Initiation and Maintenance Disorders</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

